Refine by
Surgical Products Articles & Analysis: Older
40 news found
“As with our entire suite of surgical and diagnostic products, our goal is to provide surgeons and healthcare systems with state-of-the art tools that maximize their ability to deliver optimal care for ...
(FREMONT, CA) November 14, 2022 – THINK Surgical, a technology innovator developing orthopedic surgical robots, today announced the implementation of a new, experienced commercial leadership team. Following a recent successful financing round which will enable accelerated commercialization of several new products, THINK ...
(FREMONT, CA) October 26, 2022 – THINK Surgical, a technology innovator developing orthopedic surgical robots today announced that KDB Investment Global Healthcare of Korea, a new investor, has invested $100M in the company to enable a faster commercial launch of several new products. This investment will allow THINK ...
Rob was recognized as a 2019 GameChanger by NorthBay Biz magazine and NewGen Surgical received the 2018 Green Arrow Award from the California Product Stewardship Council. ...
NewGen Surgical Inc. announced today that it has earned the U.S. Department of Agriculture (USDA) Certified Biobased Product label on all product lines. ...
Caldera Medical, a medical device company that develops best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, and Polyps announced the launch of Desara® TVez, an expansion to their Desara® Family of products. ...
Supported by the Scottish Development Agency, the Scottish-based medical device company were amongst the 4,250 other companies exhibiting at the show, where they were showcasing their revolutionary product OpLight™ – a single use, sterile, LED surgical light. ...
“Demand for minimally invasive surgical devices continues to grow and the ExsoMed products are great additions to our minimally invasive offerings,” said Milton Torres, VP of Hand and Upper Extremity at Acumed. ...
To date, NewGen Surgical customers have eliminated over 50 tons of plastic and 50 metric tons of CO2e in the healthcare supply chain with our plant-based products that are essential to surgical procedures. ...
Grupo Suprimed is one of the largest distributors of surgical, medical and hospital products in Brazil. Adilson Magri, Chief Executive Officer of Grupo Suprimed´s said, "The success and sustainability of a business in the medical field depends on improved quality of life for patients and functionality for healthcare professionals. ...
Their vast experience and service-oriented focus will ensure that Flowonix products are available to the many millions of patients who can benefit from them. ...
The acquisition will strengthen Isto’s focus on offering extraordinary solutions for surgical and clinical care procedures within spine, orthopedics, and sports medicine. ...
CMR Surgical & Surgical Innovations develop new surgical hybrid port access system Surgical Innovations’ new YelloPort Elite™ 5mm, with reusable trocar and canula, reduces cost and waste generated when compared with traditional fully single use Port Access Systems Developed with CMR ...
Activ Surgical’s first product — the ActivSight™ imaging module — seamlessly upgrades existing operating room equipment, serving as the “eyes” of the ActivEdge platform. ...
Coralville, Iowa and Deerfield, Ill., March 9, 2022 – Digital Diagnostics and Baxter International Inc. announced a long-term strategic partnership to help front line care providers deliver high-quality care and improve care outcomes. The partnership includes plans to offer Digital Diagnostics’ industry-leading IDx-DR® autonomous AI software as a diagnostic service combined with ...
The French growth company eCential Robotics, a medtech based in Grenoble specialized in surgical robotics, and the European Investment Bank (EIB) have announced the signature of a €15 million financing agreement. ...
The company's current pipeline of therapeutics target tissues deep in the ear, nose and throat passages and are designed to deliver continuous drug therapy for up to six months following a single non-invasive, in-office administration. Lyra's lead product candidate, LYR-210, is entering Phase 3 clinical development for the treatment of chronic rhinosinusitis (CRS) as an ...
The webcast replay will be available following the event. Lyra has two product candidates in development for the estimated four million CRS patients in the U.S. each year that fail medical management: LYR-210 for surgically naive patients, and LYR-220 for patients who have recurrent symptoms despite surgery. ...
He is also on the editorial boards of many scientific journals and serves as Editor for The Journal of Surgical Orthopaedic Advances (JSOA). MicroPort Orthopedics is excited to benefit from Dr. ...
We look forward to advancing the clinical development of LYR-210, and our second candidate, LYR-220 for post-surgical CRS patients, into the Phase 3 ENLIGHTEN program and Phase 2 BEACON program, respectively, around the end of this year." ...